ShadowBuys
Sign inJoin for free

Rep. Byron Donalds sold Biogen (BIIB)

Rep. Byron Donalds (R-FL-19) · $1K–$15K · traded Feb 2, 2021

Transaction
Sold
Amount
$1K–$15K
Owner
Not stated
Traded
Feb 2, 2021
Disclosed
Nov 8, 2024
Days to disclose
1375 (after the 45-day deadline)
Asset type
Other
As filed
Biogen Inc. (BIIB)
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Donalds's tradesAll Congress trades in BIIB

Other trades in this filing

All of Donalds's trades →

  • Sold Monster Beverage MNST

    $1K–$15K · Traded May 9, 2024 · disclosed Nov 8, 2024 · Spouse · filed 183 days later

  • Sold Monster Beverage MNST

    $1K–$15K · Traded May 9, 2024 · disclosed Nov 8, 2024 · filed 183 days later

  • Bought Equifax EFX

    $1K–$15K · Traded May 9, 2024 · disclosed Nov 8, 2024 · Spouse · filed 183 days later

  • Bought Equifax EFX

    $1K–$15K · Traded May 9, 2024 · disclosed Nov 8, 2024 · filed 183 days later

  • Sold Sony Group SONY

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later

  • Sold Sony Group SONY

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later

  • Sold Humana HUM

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later

  • Sold Humana HUM

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later

  • Sold Dynatrace DT

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later

  • Sold Dynatrace DT

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later

  • Bought Synopsys SNPS

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later

  • Bought Synopsys SNPS

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later

  • Bought Deckers Outdoor DECK

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later

  • Bought Deckers Outdoor DECK

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later

  • Bought AppFolio APPF

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · Spouse · filed 226 days later

  • Bought AppFolio APPF

    $1K–$15K · Traded Mar 27, 2024 · disclosed Nov 8, 2024 · filed 226 days later

  • Sold Ingersoll Rand IR

    $1K–$15K · Traded Feb 22, 2024 · disclosed Nov 8, 2024 · filed 260 days later

  • Sold General Motors Company GM

    $1K–$15K · Traded Feb 22, 2024 · disclosed Nov 8, 2024 · filed 260 days later

  • Sold Bristol-Myers Squibb Company BMY

    $1K–$15K · Traded Feb 22, 2024 · disclosed Nov 8, 2024 · filed 260 days later

  • Bought Humana HUM

    $1K–$15K · Traded Feb 22, 2024 · disclosed Nov 8, 2024 · filed 260 days later

Recent Congress trades in BIIB

Company context for BIIB

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. BIIBFinancial report·SEC EDGAR

    BIIB: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 28, 2026, 6:23 AM EDTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. BIIBCompany announcement·SEC EDGAR

    BIIB: Financial results

    Filed 8-K for an event or period dated 2026-10-28. Financial results.

    Public: Oct 28, 2026, 6:07 AM EDTEvent / period: Oct 28, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. BIIBRegulatory notice·Federal Register

    Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules

    A Notice notice explicitly mentions the company. Read the cited text for its role.

    Public: Sep 17, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.